Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Smoltek Nanotech Holding AB (publ), Interim report, Q3 2026

SMOLRegulatory press release2026-11-05 11:14
Download the release

Smoltek's CEO, Oskar Säfström, comments on the interim report.

During the third quarter of 2026, Smoltek took significant steps toward commercialization across both of its business areas. Progress in manufacturing, product development, and industrial collaborations strengthens the foundation for entering revenue-generating development, service, and licensing agreements in 2027.

 

Within Smoltek Semi, the company has established European manufacturing options for critical production stages and finalized the design specifications for the encapsulation of its ultra-thin capacitors. The first components for customer evaluation are expected to be ready toward the end of 2026, with an initial market launch targeted for 2027 within opto and high-frequency applications. Concurrently, discussions continue with potential industrial and licensing partners, offering long-term potential in power delivery for AI and advanced processors.

 

Within Smoltek Hydrogen, an important step toward industrial qualification has been initiated through an expanded collaboration with Heraeus Precious Metals. This includes a 3,000-hour durability test of Smoltek's porous transport electrode (PTE). Meanwhile, advancements in the manufacturing process are improving the prospects for future pilot production.

 

Following capital raises over the summer, the Group's cash and cash equivalents totaled SEK 45.6 million at the end of the quarter. The company's objective is to achieve positive cash flow toward the end of 2027.

 

The full interim report is available on the company's website: www.smoltek.com/investors/en 

Presentation of Q3 Interim Report
Oskar Säfström will present the company's interim report for the third quarter via a live link hosted by Redeye.

Date: November 6, 2026
Time: 11:00-12:15
Link: www.redeye.se/events/1187087/live-q-smoltek-2

Financial summary for the third quarter of 2026:

  • Net sales: SEK 0 thousand (0)
  • Group result: SEK -9,304 thousand (-7,695), primarily reflecting high activity within R&D and strategic initiatives, which strengthens long-term revenue opportunities
  • Earnings per share for the second quarter were SEK -0.04 (-0.04) before dilution
  • Equity/assets ratio: 83.7% (74.5)
  • Cash and cash equivalents: SEK 45,491 thousand (18,477)
  • Equity: SEK 118,306 thousand (81,475)
  • Cash flow from operating activities: SEK -10,952 thousand (-19,472)